BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 36071381)

  • 1. A Deeper Depth of Response After Salvage Therapy Improves Outcomes of Autologous Stem Cell Transplantation in Relapsed Lymphoma and the Feasibility of Non-controlled Rate Freezing of Peripheral Blood Stem Cells.
    Rab SU; Ali M; Mahar UR; Ahsan B; Ahmad U; Tariq Mahmood M; Siddiqui N; Bokhari SW
    Cureus; 2024 Mar; 16(3):e56851. PubMed ID: 38659569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous Stem Cell Transplant in Hodgkin's and Non-Hodgkin's Lymphoma, Multiple Myeloma, and AL Amyloidosis.
    Alnasser SM; Alharbi KS; Almutairy AF; Almutairi SM; Alolayan AM
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse impact of delay of platelet recovery after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma and multiple myeloma.
    Okada Y; Kimura F; Kurita N; Takahashi H; Shimazu Y; Mizuno S; Uchida N; Kataoka K; Hiramoto N; Ota S; Kako S; Tsukada N; Kanda Y; Kurahashi S; Doki N; Nishikawa A; Kim SW; Hangaishi A; Kanda J; Fukuda T; Atsuta Y; Kondo E; Kawamura K; Nakasone H
    Cytotherapy; 2023 Nov; 25(11):1212-1219. PubMed ID: 37354150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of body composition and outcomes following autologous hematopoietic stem cell transplantation in patients with non-Hodgkin lymphoma.
    Aleixo GFP; Wei W; Chen PH; Gandhi NS; Anwer F; Dean R; Hamilton BK; Hill BT; Jagadeesh D; Khouri J; Pohlman B; Sobecks R; Winter A; Caimi P; Majhail NS
    Bone Marrow Transplant; 2023 Dec; 58(12):1384-1389. PubMed ID: 37699993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Country Report: The Report of Transplant Activity and Outcome During the First 12 Months at the First National Hematopoietic Stem Cell Transplant Center in Sri Lanka.
    Abeysinghe P; Morawaka L; Gunasekara S; Suresh S; Jayathilake P; Udara P; Siriwardena P; Milliken S; Moore J; Ma D
    Blood Cell Ther; 2019 Nov; 2(4):50-53. PubMed ID: 37588103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early infections after autologous transplantation for haematological malignancies.
    Schiødt I; Bergmann OJ; Johnsen HE; Hansen NE
    Med Oncol; 1998 Jul; 15(2):103-8. PubMed ID: 9789217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Families with non-Hodgkin lymphoma and plasma cell dyscrasias in their pedigrees.
    Wiernik PH; Dutcher JP
    J Investig Med; 2024 Jan; 72(1):26-31. PubMed ID: 37864488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous hematopoietic stem cell transplant at a tertiary care centre in India: achieving comparable outcomes with adaptations.
    Gupta AK; Meena JP; Seth R; Naranje P; Mohanty S; Coshic P
    Blood Cell Ther; 2024 Feb; 7(1):25-32. PubMed ID: 38486828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematological malignancies in East Africa-Which cancers to expect and how to provide services.
    Leak SA; Mmbaga LG; Mkwizu EW; Mapendo PJ; Henke O
    PLoS One; 2020; 15(5):e0232848. PubMed ID: 32374771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transient Leukemoid Reaction from T-Cell Large Granular Lymphocytes Post Autologous Stem Cell Transplant in a Patient Affected by Hodgkin Lymphoma.
    Duminuco A; Parisi M; Milone GA; Cupri A; Leotta S; Palumbo GA; Parrinello NL; Scuderi G; Triolo A; Milone G
    Hematol Rep; 2023 Oct; 15(4):555-561. PubMed ID: 37873793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Late mortality and causes of death among long-term survivors after autologous hematopoietic stem cell transplantation.
    Iida M; Nakasone H; Yamashita T; Inoue M; Ishida Y; Uchiyama H; Katayama Y; Miyamoto T; Yoshioka S; Shiratori S; Mori T; Sawa M; Sugio Y; Fukuda T; Ichinohe T; Atsuta Y; Inamoto Y;
    Blood Cell Ther; 2020 Feb; 3(1):11-17. PubMed ID: 37465377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of atrial fibrillation and various cancer subtypes.
    Zubair Khan M; Gupta A; Patel K; Abraham A; Franklin S; Kim DY; Patel K; Hussian I; Zarak MS; Figueredo V; Kutalek S
    J Arrhythm; 2021 Oct; 37(5):1205-1214. PubMed ID: 34621418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time from Symptom Onset to Diagnosis and Treatment among Haematological Malignancies: Influencing Factors and Associated Negative Outcomes.
    Dapkevičiūtė A; Šapoka V; Martynova E; Pečeliūnas V
    Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31163661
    [No Abstract]   [Full Text] [Related]  

  • 14. [How I treat non-Hodgkin's lymphoma by autologous hematopoietic stem cell transplantation].
    Zhang X
    Zhonghua Xue Ye Xue Za Zhi; 2018 Feb; 39(2):94-97. PubMed ID: 29562440
    [No Abstract]   [Full Text] [Related]  

  • 15. Autologous hematopoietic transplantation following COVID-19 infection.
    Brzycki M; Richard R; Burwick N; Graf S; O'Brien C; Wu D; Chauncey TR
    Clin Case Rep; 2021 Mar; 9(3):1167-1170. PubMed ID: 33768803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fertility outcomes in patients desiring conception following autologous stem cell transplantation for hodgkin lymphoma using LACE conditioning.
    Jindal N; C M; Mathew LJ; Kumbhalwar K; Patel K; Garg M; Mirgh S; Chichra A; Nayak L; Bonda A; Gokarn A; Punatar S; Bagal B; Khattry N
    Bone Marrow Transplant; 2024 Mar; 59(3):417-418. PubMed ID: 38102211
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidemiology of early infections and predictors of mortality after autologous hematopoietic stem-cell transplantation among multiple myeloma, Hodgkin, and non-Hodgkin lymphoma: the first experience from Palestine.
    Amer R; Salameh H; Mosleh S; Abu-Taha A; Hamayel H; Enaya A; Adas A; Khursani A; Wild-Ali M; Mousa T; Battat M; Daifallah A; Koni A; Shawahna R
    BMC Infect Dis; 2022 Sep; 22(1):725. PubMed ID: 36071381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematopoietic stem cell transplantation does not increase the risk of infection-related complications for pediatric patients with Hodgkin and non-Hodgkin lymphomas: A multicenter nationwide study.
    Zając-Spychała O; Wachowiak J; Czyżewski K; Dziedzic M; Wysocki M; Zalas-Więcek P; Szmydki-Baran A; Hutnik Ł; Matysiak M; Małas Z; Badowska W; Gryniewicz-Kwiatkowska O; Gietka A; Dembowska-Bagińska B; Semczuk K; Dzierżanowska-Fangrat K; Bartnik M; Ociepa T; Urasiński T; Frączkiewicz J; Salamonowicz M; Kałwak K; Gorczyńska E; Chybicka A; Irga-Jaworska N; Bień E; Drożyńska E; Chełmecka-Wiktorczyk L; Balwierz W; Zak I; Pierlejewski F; Młynarski W; Urbanek-Dądela A; Karolczyk G; Stolpa W; Sobol-Milejska G; Płonowski M; Krawczuk-Rybak M; Musiał J; Chaber R; Gamrot-Pyka Z; Woszczyk M; Tomaszewska R; Szczepański T; Kowalczyk J; Styczyński J
    Transpl Infect Dis; 2020 Aug; 22(4):e13292. PubMed ID: 32285579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infectious complications after autologous hematopoietic stem cell transplantation: comparison of patients with acute myeloid leukemia, malignant lymphoma, and multiple myeloma.
    Auner HW; Sill H; Mulabecirovic A; Linkesch W; Krause R
    Ann Hematol; 2002 Jul; 81(7):374-7. PubMed ID: 12185506
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.